Introduction: Patients with mental deficiency have increased health needs. They develop certain ailments more than the rest of the general population. ENT pathology includes all the ailments concerning the nose, throat and ear and is a frequent reason for consultation in our health facilities. The aim of this study was to report the prevalence of ENT diseases in mental deficient. Material and Methods: This was a prospective, longitudinal study on a population of patients received in ENT consultation, during the days of October 15, 2019 and February 18, 2020 on the occasion of health campaigns organized by the Senegal Special Olympics Association. All admitted patients were mental deficient. Results: Out of a total of 334 patients received in general consultation (all specialties combined), 61 patients underwent an ENT consultation, i.e. a prevalence of 18.26%. There were more men (N = 39) than women (N = 32). The average age of the patients was 20 years. A past history of chronic otitis media was reported in 9.83% of patients (N = 6). Functional signs were dominated by hypoacusis (N = 16). Seventy point forty-nine patients (N = 43) had otologic conditions. Thirty-four patients had trisomy 21 (64.15%). Conclusion: The prevalence of ENT diseases among the mental deficient is considerable. This study is the first of its type in Senegal which superimposes the ENT on mental deficiency.
34Open Journal of Psychiatry perpetrators, most of whom were known to their victims. The policy to fight sexual violence against children must integrate sex education at school and community level, public awareness, monitoring of child sex offenders and possibly, their medico-psychological care.
Background and Objectives: The acute acute delirious puff named BDA in french, from French psychiatric nosology, is similar to schizophreniform disorder (CIM) and brief psychotic disorder (DSM). In Africa, its prevalence is between 11.34% and 32% [3-5]. The aim of our study was to determine the epidemiological and clinical and characteristics of BDA in hospitalization at the Psychiatric Center of Ziguinchor. Methodology: It was a retrospective, descriptive study carried out at the Emile Badiane Psychiatric Center (CPEB) in Ziguinchor, which focused on the records of patients followed in this center from January 1, 2014 to December 31, 2019. All patients hospitalized for BDA during the study period were included. Results: In total out of 1370 hospitalizations recorded, 400 were for BDA, i.e. a hospital prevalence of 29.1%. Men represented 67.9% of the workforce. The mean age was 32.09 ± 11.62 years. The age group [20 to 39] represented 68% of the workforce. Family psychiatric history was found in 33.8% of cases. Hospitalization in the first month following the onset of the disease occurred in 54.7% of cases. Cannabis consumption was found in 102 cases, polymorphic delirium in 55.6%, persecution in 92,6% and the hallucinatory mechanism in 51.7%. Behavioral disorder was noted in 86.2% of our patients, including 28.3% physical and/or verbal aggression. The average duration of hospitalization was 19.75 ± 8.9 days with extremes of 2 and 62 days. Normal output was 89.7%. Persistence of delirium at discharge was noted in 30 patients (8.8%). Neuroleptics were used in 33.2% of cases. Conclusion: Our study confirms the prevalence of BDA in Africa which remains high. It occurs in a young adult, male, single, educated, unemployed and with a family psychiatric history. It is characterized by a predominantly “persecutive” polymorphic delirium with a hallucinatory mechanism responding favorably to neuroleptics after a 19-day hospital stay. It also shows the need to encourage the proliferation of psychiatric care centers such as that of Ziguinchor, which draws a good part of the patients from the south of the country.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.